Sponsor Pipeline

Lepu Biopharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
1
Phase 3
5
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-29 NCT07479485
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-30 NCT07737600 A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07138846 A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive… Advanced Pancreatic Cancer Not Yet Recruiting
Phase 2
NCT07283835 Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer… Non Muscle Invasive Bladder Cancer Recruiting
NCT07586124 Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced… Head and Neck Squamous Cell Carcinoma Recruiting
Phase 1/2
NCT07093970 A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07479485 MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) Hepatocellular Carcinoma Recruiting
NCT07737600 A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer Advanced Colorectal Cancer Not Yet Recruiting
Disease Areas
Get alerts when Lepu Biopharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free